Clinical trial
Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute…
NCT00373451 · Deutsches Herzzentrum Muenchen, Other · Completed
Key facts
| NCT number | NCT00373451 |
|---|---|
| Title | Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome |
| Official title | Randomized, Double-Blind, Active-Controlled, Multicenter Trial of Abciximab And Bivalirudin in Patients With Non-ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Interventions (ISAR-REACT-4) |
| Acronym | ISAR-REACT-4 |
| Lead sponsor | Deutsches Herzzentrum Muenchen, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Myocardial Infarction, Coronary Disease |
| Intervention type | Drug |
| Interventions | Abciximab + UFH, Bivalirudin, Heparin |
| Enrollment | 1,721 |
| Start date | Jul 1, 2006 |
| Primary completion | May 1, 2011 |
| Completion | Jul 1, 2011 |
| First posted | Sep 8, 2006 |
| Last update posted | May 8, 2012 |
| Countries | Germany, Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: